Are Your Reprocessed Single Use Devices, EU MDR Ready?

by | Jun 19, 2019 | EU, EU MDR, FDA, Medical Devices, Pharmaceuticals, Quality Systems, Regulatory

With less than a year until the end of the EU MDR transition period, it is pertinent to ensure that all devices to be sold in Europe comply. We’ve been highlighting many of the new requirements in our blogs, including:

INTRODUCTION TO CLINICAL EVALUATION REPORTS (CERS),

TRANSITIONING TO THE EU MDR? DO YOU HAVE A PRRC YET?

WHAT THE NEW EU MDR MEANS TO YOUR REVENUE

DO YOU KNOW WHAT YOUR TECH FILE SHOULD INCLUDE?

Prior to the MDR, there was no single European standard or regulation for single-use device (SUD) reprocessing, but now those who reprocess SUDs are being held to the same obligations as manufacturers. This update does not allow SUDs to be reprocessed across Europe as each nation’s law must permit and regulate it. Article 17 outlines the requirements specific to SUDs.1

Often, healthcare institutions may reprocess SUDs as a cost reducing initiative. If this is the case, EU Member States will be allowed to apply their own rules so long as they ensure equivalent safety and performance and adhere to the common specifications regarding risk management, validation, testing, quality management systems, incident reporting, and traceability.1

While each Member State is allowed to regulate SUDs themselves, the EU MDR is very specific on what SUDs can be reprocessed and the standards each reprocessed device shall meet. Keeping with the theme of the rest of the MDR, patient safety is at the forefront of SUD reprocessing regulations. Only devices on the market in accordance with the MDR and/or Directive 93/42/EEC and deemed safe through scientific evidence will be allowed to be reprocessed. Additionally, the label will have to be updated to include the fact that it was reprocessed and remove the original manufacturers’ information, which shall be included in the instructions.1

If you are currently reprocessing SUDs, but need help ensuring you are compliant with the updated regulations, reach out to us at 248-987-4497 or email info@emmainternational.com.


1 Official Journal of the European Union – REGULATION (EU) 2017/745 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL retrieved on 06/14/2019 from https://eur-lex.europa.eu/legal-content/ENG/TXT/PDF/?uri=CELEX:32017R0745&from=EN.

Jayme Brace

Jayme Brace

More Resources

The End of the COVID-19 Public Health Emergency

The End of the COVID-19 Public Health Emergency

After over 3 years, the COVID-19 Public Health Emergency (PHE) will end on May 11, 2023, the Biden Administration announced last week.1After 3.5 years of the modified policy to allow for amore efficient path for COVID-19-related medical products to get to market, this begs the question of how it will impact the MedTech world.
Process Validation

Process Validation

All right, you have just gotten all of your paperwork together, submitted the right forms to the right people, set up your factory, hired and trained your staff; now it’s time to make the medical devices. The regulatory nonsense is over and done, right?
The Role of Management in Product Quality

The Role of Management in Product Quality

Depending on the factory, some production employees may find it surprising that management has an important role to play in a quality system.  21 CFR 820.20 mandates that “Management with executive responsibility shall establish objectives for, and commitment to, quality”.[1]  The Federal Government expects that management takes an active interest in improving the output of their company, at least in the case of medical device manufacturers.

Ready to learn more about working with us?

Pin It on Pinterest

Share This